Medical Devices & Consumables

Global Heparin Anti-thrombogenic Coating Market Research Report 2026

This report delivers a comprehensive overview of the global Heparin Anti-thrombogenic Coating market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Heparin Anti-thrombogenic Coating. The Heparin Anti-thrombogenic Coating market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Heparin Anti-thrombogenic Coating market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Heparin Anti-thrombogenic Coating manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
WL Gore & Associates
Biointeractions
Toyobo
Surmodics
Corline Biomedical
jMedtech
Biosurf
Segment by Type
Anticoagulant Heparin Coatings
Anti-inflammatory Heparin Coatings
Dual-Function Coatings
Segment by Application
Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Heparin Anti-thrombogenic Coating companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heparin Anti-thrombogenic Coating Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Anticoagulant Heparin Coatings
1.2.3 Anti-inflammatory Heparin Coatings
1.2.4 Dual-Function Coatings
1.3 Market by Application
1.3.1 Global Heparin Anti-thrombogenic Coating Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cardiovascular Devices
1.3.3 Catheters and Cannulas
1.3.4 Dialysis and Extracorporeal Circuits
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Heparin Anti-thrombogenic Coating Market Perspective (2021–2032)
2.2 Global Heparin Anti-thrombogenic Coating Growth Trends by Region
2.2.1 Global Heparin Anti-thrombogenic Coating Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Heparin Anti-thrombogenic Coating Historic Market Size by Region (2021–2026)
2.2.3 Heparin Anti-thrombogenic Coating Forecasted Market Size by Region (2027–2032)
2.3 Heparin Anti-thrombogenic Coating Market Dynamics
2.3.1 Heparin Anti-thrombogenic Coating Industry Trends
2.3.2 Heparin Anti-thrombogenic Coating Market Drivers
2.3.3 Heparin Anti-thrombogenic Coating Market Challenges
2.3.4 Heparin Anti-thrombogenic Coating Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Heparin Anti-thrombogenic Coating Players by Revenue
3.1.1 Global Top Heparin Anti-thrombogenic Coating Players by Revenue (2021–2026)
3.1.2 Global Heparin Anti-thrombogenic Coating Revenue Market Share by Players (2021–2026)
3.2 Global Top Heparin Anti-thrombogenic Coating Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Heparin Anti-thrombogenic Coating Revenue
3.4 Global Heparin Anti-thrombogenic Coating Market Concentration Ratio
3.4.1 Global Heparin Anti-thrombogenic Coating Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heparin Anti-thrombogenic Coating Revenue in 2025
3.5 Global Key Players of Heparin Anti-thrombogenic Coating Head Offices and Areas Served
3.6 Global Key Players of Heparin Anti-thrombogenic Coating, Products and Applications
3.7 Global Key Players of Heparin Anti-thrombogenic Coating, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Heparin Anti-thrombogenic Coating Breakdown Data by Type
4.1 Global Heparin Anti-thrombogenic Coating Historic Market Size by Type (2021–2026)
4.2 Global Heparin Anti-thrombogenic Coating Forecasted Market Size by Type (2027–2032)
5 Heparin Anti-thrombogenic Coating Breakdown Data by Application
5.1 Global Heparin Anti-thrombogenic Coating Historic Market Size by Application (2021–2026)
5.2 Global Heparin Anti-thrombogenic Coating Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Heparin Anti-thrombogenic Coating Market Size (2021–2032)
6.2 North America Heparin Anti-thrombogenic Coating Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Heparin Anti-thrombogenic Coating Market Size by Country (2021–2026)
6.4 North America Heparin Anti-thrombogenic Coating Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Heparin Anti-thrombogenic Coating Market Size (2021–2032)
7.2 Europe Heparin Anti-thrombogenic Coating Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Heparin Anti-thrombogenic Coating Market Size by Country (2021–2026)
7.4 Europe Heparin Anti-thrombogenic Coating Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Heparin Anti-thrombogenic Coating Market Size (2021–2032)
8.2 Asia-Pacific Heparin Anti-thrombogenic Coating Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Heparin Anti-thrombogenic Coating Market Size by Region (2021–2026)
8.4 Asia-Pacific Heparin Anti-thrombogenic Coating Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Heparin Anti-thrombogenic Coating Market Size (2021–2032)
9.2 Latin America Heparin Anti-thrombogenic Coating Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Heparin Anti-thrombogenic Coating Market Size by Country (2021–2026)
9.4 Latin America Heparin Anti-thrombogenic Coating Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Heparin Anti-thrombogenic Coating Market Size (2021–2032)
10.2 Middle East & Africa Heparin Anti-thrombogenic Coating Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Heparin Anti-thrombogenic Coating Market Size by Country (2021–2026)
10.4 Middle East & Africa Heparin Anti-thrombogenic Coating Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WL Gore & Associates
11.1.1 WL Gore & Associates Company Details
11.1.2 WL Gore & Associates Business Overview
11.1.3 WL Gore & Associates Heparin Anti-thrombogenic Coating Introduction
11.1.4 WL Gore & Associates Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.1.5 WL Gore & Associates Recent Development
11.2 Biointeractions
11.2.1 Biointeractions Company Details
11.2.2 Biointeractions Business Overview
11.2.3 Biointeractions Heparin Anti-thrombogenic Coating Introduction
11.2.4 Biointeractions Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.2.5 Biointeractions Recent Development
11.3 Toyobo
11.3.1 Toyobo Company Details
11.3.2 Toyobo Business Overview
11.3.3 Toyobo Heparin Anti-thrombogenic Coating Introduction
11.3.4 Toyobo Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.3.5 Toyobo Recent Development
11.4 Surmodics
11.4.1 Surmodics Company Details
11.4.2 Surmodics Business Overview
11.4.3 Surmodics Heparin Anti-thrombogenic Coating Introduction
11.4.4 Surmodics Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.4.5 Surmodics Recent Development
11.5 Corline Biomedical
11.5.1 Corline Biomedical Company Details
11.5.2 Corline Biomedical Business Overview
11.5.3 Corline Biomedical Heparin Anti-thrombogenic Coating Introduction
11.5.4 Corline Biomedical Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.5.5 Corline Biomedical Recent Development
11.6 jMedtech
11.6.1 jMedtech Company Details
11.6.2 jMedtech Business Overview
11.6.3 jMedtech Heparin Anti-thrombogenic Coating Introduction
11.6.4 jMedtech Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.6.5 jMedtech Recent Development
11.7 Biosurf
11.7.1 Biosurf Company Details
11.7.2 Biosurf Business Overview
11.7.3 Biosurf Heparin Anti-thrombogenic Coating Introduction
11.7.4 Biosurf Revenue in Heparin Anti-thrombogenic Coating Business (2021–2026)
11.7.5 Biosurf Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Heparin Anti-thrombogenic Coating Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Anticoagulant Heparin Coatings
Table 3. Key Players of Anti-inflammatory Heparin Coatings
Table 4. Key Players of Dual-Function Coatings
Table 5. Global Heparin Anti-thrombogenic Coating Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Heparin Anti-thrombogenic Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Heparin Anti-thrombogenic Coating Market Size by Region (US$ Million), 2021–2026
Table 8. Global Heparin Anti-thrombogenic Coating Market Share by Region (2021–2026)
Table 9. Global Heparin Anti-thrombogenic Coating Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Heparin Anti-thrombogenic Coating Market Share by Region (2027–2032)
Table 11. Heparin Anti-thrombogenic Coating Market Trends
Table 12. Heparin Anti-thrombogenic Coating Market Drivers
Table 13. Heparin Anti-thrombogenic Coating Market Challenges
Table 14. Heparin Anti-thrombogenic Coating Market Restraints
Table 15. Global Heparin Anti-thrombogenic Coating Revenue by Players (US$ Million), 2021–2026
Table 16. Global Heparin Anti-thrombogenic Coating Market Share by Players (2021–2026)
Table 17. Global Top Heparin Anti-thrombogenic Coating Players by Tier (Tier 1, Tier 2, and Tier 3), based on Heparin Anti-thrombogenic Coating Revenue, 2025
Table 18. Ranking of Global Top Heparin Anti-thrombogenic Coating Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Heparin Anti-thrombogenic Coating Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Heparin Anti-thrombogenic Coating, Headquarters and Area Served
Table 21. Global Key Players of Heparin Anti-thrombogenic Coating, Products and Applications
Table 22. Global Key Players of Heparin Anti-thrombogenic Coating, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Heparin Anti-thrombogenic Coating Market Size by Type (US$ Million), 2021–2026
Table 25. Global Heparin Anti-thrombogenic Coating Revenue Market Share by Type (2021–2026)
Table 26. Global Heparin Anti-thrombogenic Coating Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Heparin Anti-thrombogenic Coating Revenue Market Share by Type (2027–2032)
Table 28. Global Heparin Anti-thrombogenic Coating Market Size by Application (US$ Million), 2021–2026
Table 29. Global Heparin Anti-thrombogenic Coating Revenue Market Share by Application (2021–2026)
Table 30. Global Heparin Anti-thrombogenic Coating Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Heparin Anti-thrombogenic Coating Revenue Market Share by Application (2027–2032)
Table 32. North America Heparin Anti-thrombogenic Coating Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2021–2026
Table 34. North America Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Heparin Anti-thrombogenic Coating Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Heparin Anti-thrombogenic Coating Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Heparin Anti-thrombogenic Coating Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Heparin Anti-thrombogenic Coating Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Heparin Anti-thrombogenic Coating Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Heparin Anti-thrombogenic Coating Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Heparin Anti-thrombogenic Coating Market Size by Country (US$ Million), 2027–2032
Table 47. WL Gore & Associates Company Details
Table 48. WL Gore & Associates Business Overview
Table 49. WL Gore & Associates Heparin Anti-thrombogenic Coating Product
Table 50. WL Gore & Associates Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 51. WL Gore & Associates Recent Development
Table 52. Biointeractions Company Details
Table 53. Biointeractions Business Overview
Table 54. Biointeractions Heparin Anti-thrombogenic Coating Product
Table 55. Biointeractions Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 56. Biointeractions Recent Development
Table 57. Toyobo Company Details
Table 58. Toyobo Business Overview
Table 59. Toyobo Heparin Anti-thrombogenic Coating Product
Table 60. Toyobo Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 61. Toyobo Recent Development
Table 62. Surmodics Company Details
Table 63. Surmodics Business Overview
Table 64. Surmodics Heparin Anti-thrombogenic Coating Product
Table 65. Surmodics Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 66. Surmodics Recent Development
Table 67. Corline Biomedical Company Details
Table 68. Corline Biomedical Business Overview
Table 69. Corline Biomedical Heparin Anti-thrombogenic Coating Product
Table 70. Corline Biomedical Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 71. Corline Biomedical Recent Development
Table 72. jMedtech Company Details
Table 73. jMedtech Business Overview
Table 74. jMedtech Heparin Anti-thrombogenic Coating Product
Table 75. jMedtech Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 76. jMedtech Recent Development
Table 77. Biosurf Company Details
Table 78. Biosurf Business Overview
Table 79. Biosurf Heparin Anti-thrombogenic Coating Product
Table 80. Biosurf Revenue in Heparin Anti-thrombogenic Coating Business (US$ Million), 2021–2026
Table 81. Biosurf Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
Table 85. Authors List of This Report


List of Figures
Figure 1. Heparin Anti-thrombogenic Coating Picture
Figure 2. Global Heparin Anti-thrombogenic Coating Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Heparin Anti-thrombogenic Coating Market Share by Type: 2025 vs 2032
Figure 4. Anticoagulant Heparin Coatings Features
Figure 5. Anti-inflammatory Heparin Coatings Features
Figure 6. Dual-Function Coatings Features
Figure 7. Global Heparin Anti-thrombogenic Coating Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Heparin Anti-thrombogenic Coating Market Share by Application: 2025 vs 2032
Figure 9. Cardiovascular Devices Case Studies
Figure 10. Catheters and Cannulas Case Studies
Figure 11. Dialysis and Extracorporeal Circuits Case Studies
Figure 12. Others Case Studies
Figure 13. Heparin Anti-thrombogenic Coating Report Years Considered
Figure 14. Global Heparin Anti-thrombogenic Coating Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Heparin Anti-thrombogenic Coating Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Heparin Anti-thrombogenic Coating Market Share by Region: 2025 vs 2032
Figure 17. Global Heparin Anti-thrombogenic Coating Market Share by Players in 2025
Figure 18. Global Heparin Anti-thrombogenic Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Heparin Anti-thrombogenic Coating Revenue in 2025
Figure 20. North America Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Heparin Anti-thrombogenic Coating Market Share by Country (2021–2032)
Figure 22. United States Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Heparin Anti-thrombogenic Coating Market Share by Country (2021–2032)
Figure 26. Germany Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Heparin Anti-thrombogenic Coating Market Share by Region (2021–2032)
Figure 34. China Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Heparin Anti-thrombogenic Coating Market Share by Country (2021–2032)
Figure 42. Mexico Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Heparin Anti-thrombogenic Coating Market Share by Country (2021–2032)
Figure 46. Israel Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Heparin Anti-thrombogenic Coating Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. WL Gore & Associates Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 50. Biointeractions Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 51. Toyobo Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 52. Surmodics Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 53. Corline Biomedical Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 54. jMedtech Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 55. Biosurf Revenue Growth Rate in Heparin Anti-thrombogenic Coating Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies